Concepedia

Publication | Open Access

Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia

185

Citations

17

References

2019

Year

Abstract

After achieving normokalemia, individualized once daily sodium zirconium cyclosilicate was associated with maintenance of normokalemia without substantial renin-angiotensin-aldosterone system inhibitor changes for ≤12 months.

References

YearCitations

Page 1